Barclays’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.22M Buy
99,999
+43,780
+78% +$972K ﹤0.01% 2159
2025
Q1
$1.05M Sell
56,219
-27,348
-33% -$509K ﹤0.01% 2421
2024
Q4
$1.11M Buy
83,567
+39,267
+89% +$520K ﹤0.01% 2579
2024
Q3
$1.49M Buy
44,300
+23,926
+117% +$803K ﹤0.01% 2388
2024
Q2
$510K Sell
20,374
-8,948
-31% -$224K ﹤0.01% 2526
2024
Q1
$659K Buy
29,322
+14
+0% +$315 ﹤0.01% 2677
2023
Q4
$628K Sell
29,308
-6,761
-19% -$145K ﹤0.01% 2876
2023
Q3
$647K Sell
36,069
-12,593
-26% -$226K ﹤0.01% 2384
2023
Q2
$990K Buy
48,662
+14,308
+42% +$291K ﹤0.01% 2162
2023
Q1
$748K Sell
34,354
-5,997
-15% -$131K ﹤0.01% 2342
2022
Q4
$1.25M Sell
40,351
-8,422
-17% -$261K ﹤0.01% 1971
2022
Q3
$1.24M Buy
48,773
+47,755
+4,691% +$1.22M ﹤0.01% 1967
2022
Q2
$21K Sell
1,018
-2,195
-68% -$45.3K ﹤0.01% 4063
2022
Q1
$80K Sell
3,213
-20,190
-86% -$503K ﹤0.01% 3777
2021
Q4
$813K Buy
23,403
+11,674
+100% +$406K ﹤0.01% 2311
2021
Q3
$319K Buy
11,729
+8,004
+215% +$218K ﹤0.01% 2786
2021
Q2
$97K Sell
3,725
-14,174
-79% -$369K ﹤0.01% 3142
2021
Q1
$386K Buy
17,899
+10,520
+143% +$227K ﹤0.01% 2800
2020
Q4
$158K Sell
7,379
-12,461
-63% -$267K ﹤0.01% 2804
2020
Q3
$292K Sell
19,840
-4,052
-17% -$59.6K ﹤0.01% 2557
2020
Q2
$534K Sell
23,892
-154,379
-87% -$3.45M ﹤0.01% 2292
2020
Q1
$2.52M Buy
178,271
+149,556
+521% +$2.11M ﹤0.01% 1214
2019
Q4
$466K Buy
28,715
+594
+2% +$9.64K ﹤0.01% 2732
2019
Q3
$984K Sell
28,121
-5,018
-15% -$176K ﹤0.01% 2268
2019
Q2
$1.87M Buy
33,139
+12,858
+63% +$726K ﹤0.01% 1865
2019
Q1
$1.48M Buy
20,281
+6,007
+42% +$439K ﹤0.01% 1819
2018
Q4
$911K Sell
14,274
-110,318
-89% -$7.04M ﹤0.01% 1875
2018
Q3
$12.4M Buy
124,592
+112,067
+895% +$11.2M 0.01% 699
2018
Q2
$890K Buy
12,525
+3,644
+41% +$259K ﹤0.01% 1941
2018
Q1
$924K Buy
8,881
+6,051
+214% +$630K ﹤0.01% 1868
2017
Q4
$285K Buy
2,830
+2,552
+918% +$257K ﹤0.01% 2451
2017
Q3
$10K Sell
278
-226
-45% -$8.13K ﹤0.01% 3417
2017
Q2
$12K Sell
504
-427
-46% -$10.2K ﹤0.01% 3390
2017
Q1
$26K Buy
+931
New +$26K ﹤0.01% 3296